- Home
- A-Z Publications
- Current Diabetes Reviews
- Previous Issues
- Volume 20, Issue 1, 2024
Current Diabetes Reviews - Volume 20, Issue 1, 2024
Volume 20, Issue 1, 2024
-
-
Maturity-onset Diabetes of the Young Type 7 (MODY7) and the Krüppellike Factor 11 Mutation (KLF11). A Review
Introduction: Maturity-onset diabetes of the young (MODY) is a rare disease due to a single gene mutation that affects several family members in most cases. The Krüppel-like factor 11 (KLF11) gene mutation is associated with decreased insulin sensitivity to high glucose levels. KLF 11 has been implicated in the pathogenesis of MODY type 7 but given its low prevalence, prolonged subclinical period, and the emergence of n Read More
-
-
-
Centenary of Insulin Therapy: A Review
Authors: Abrar A. Zargar, Ranjeet Kumar, Arvind Kumar, Ruby Gangwar and Amit SharmaInsulin is an endocrine hormone produced by the beta cells of islets of Langerhans in the pancreas. It regulates blood sugar levels and various anabolic activities such as glycogenesis and lipid synthesis. Despite the fact that insulin therapy has been around for 100 years, insulin formulations are continually being improved to lower the risk of hypoglycaemia and other adverse effects, including weight gain. The development of Read More
-
-
-
Diverse Approaches toward Application of Dental Pulp Stem Cells from Human Permanent and Deciduous Teeth in the Treatment of Diabetes
Authors: Mohammad M. Kanafi and Ramesh Ramchandra BhondeBackground: Diabetes Mellitus is defined by hyperglycemia, a condition which is the result of defects in insulin secretion, insulin action, or both. Evidence suggest that islet transplantation is a promising treatment approach, but the shortage of sources of insulin-producing cells is a major problem. Ethical concerns and the limited availability of most stem cells have led scientists to concentrate on mesenchymal stem cells, Read More
-
-
-
Insulin Glargine in Type 1 Diabetes Mellitus: A Review of Clinical Trials and Real-world Evidence Across Two Decades
Background: Over the past two decades, insulin glargine 100 U/mL (Gla-100) has emerged as the "standard of care" basal insulin for the management of type 1 diabetes mellitus (T1DM). Both formulations, insulin glargine 100 U/mL (Gla-100) and glargine 300 U/mL (Gla- 300) have been extensively studied against various comparator basal insulins across various clinical and real-world studies. In this comprehensive Read More
-
-
-
Effect of Ankle Brachial Index (ABI) and Compression Therapy on Diabetic Foot Ulcer Healing
Authors: Asmat Burhan, Fitri Arofiati, Vanessa A. Da Silva and Septian Mixrova SebayangPurpose: Knowing the effect of compression therapy on the value of the Ankle Brachial Index in the healing process of Diabetic Foot Ulcer. Design: This study used a quasi-experimental method with pretest-posttest with control group design with purposive sampling and non-equivalent control groups for eight weeks of treatment. Subjects and Setting: Patients diagnosed with Diabetic Foot Ulcer have and have Peripheral Artery Read More
-
-
-
Effect of Vitamin D on Retinoblastoma Protein in Prediabetic Individuals
Authors: Dakshita Hardatt, Manju Devi, Sonal Vyas, Gurvinder Singh, Jyoti Jain, Sumeet Gupta and Meenakshi DhanawatAbout 50.8 million people were diagnosed with diabetes in 2011; the count has increased by 10 million in the last five years. Type-1 diabetes could occur at any age, but predominantly in children and young adults. The risk of developing type II diabetes mellitus in the offspring of parents with DM II is 40% if one parent has DM II and approaches 70% if both parents have DM II. The process of developing diabetes from normal gluco Read More
-
-
-
Diabetes and TB: Confluence of Two Epidemic and Its Effect on Clinical Presentation
Background: Tuberculosis (TB) has become a rising concern in low-income countries, particularly in those with Human Immuno Deficiency Virus (HIV) epidemics, and type 2 diabetes has emerged as a significant global chronic health problem, owing to increases in obesity, lifestyle changes, and ageing populations. Diabetes has been identified as a major risk factor for the development of TB. Despite the fact that diabetes im Read More
-
-
-
Biomarkers for Diabetic Nephropathy with a Focus on Kidney Injury Molecule-1 (KIM-1)
Authors: Fatemeh Khonsha, Mohammad Valilo, Hamid-Reza Nejabati, Mohammad Rahmati-Yamchi and Ali MotaDiabetic Nephropathy (DN), with an increasing rate of mortality and morbidity, is considered the main cause of End-Stage Renal Disease (ESRD). A wide spectrum of biomarkers exist for early detection of DN, but they suffer from low specificity and sensitivity, indicating the urgent demand for finding more effective biomarkers. Also, the pathophysiology of tubular damage and its relation to DN are not yet completely understoo Read More
-
-
-
Prevalence and Associated Factors of Toenail Onychomycosis Among Patients with Diabetes in Jordan
Authors: Hesham Alrauosh, Anas Ababneh, Faris G. Bakri, Mousa Abujbara, Hashem Kanaan and Nidal A. YounesBackground: Toenail onychomycosis is common in patients with diabetes and it can increase the risk of secondary infections and foot complications. Despite several studies investigating the prevalence and associated factors of toenail onychomycosis from different parts of the world, there are no data from Jordan. Objective: To determine the prevalence and the associated factors of toenail onychomycosis among patients with diab Read More
-
-
-
Review on In-vitro Techniques and In-vivo Animals Models for Screening Diabetes and Diabetic Complications
Authors: Shivam, Sushil Kumar and Asheesh K. GuptaDiabetes mellitus is a type of metabolic disorders. Various pharmaceutical interventions and animal models have been used to investigate the genetic, environmental, and etiological aspects of diabetes and its effects. In recent years for the development of ant-diabetic remedies, numerous novel genetically modified animals, pharmaceutical substances, medical techniques, viruses, and hormones have been developed to scr Read More
-
-
-
Prevalence, Incidence and Factors Associated with Diabetic Foot in People with Type 2 Diabetes: Systematic Review with Meta-Analysis
Background: Diabetic Foot is a severe chronic complication of diabetes and an important factor in the morbidity of diabetic people, resulting in high health costs and increased risk of death. Objective: To analyze the incidence, prevalence, and risk factors associated with diabetic foot in people with type 2 Diabetes Mellitus. Method: Systematic literature review. Searches in MedLine via PubMed, LILACS, Web of Science, Scopus CI Read More
-
-
-
Prevalence of Diabetes in India: A Review of IDF Diabetes Atlas 10th Edition
Authors: Arvind Kumar, Ruby Gangwar, Abrar Ahmad Zargar, Ranjeet Kumar and Amit SharmaDiabetes is a severe chronic disease that arises when insulin generation is insufficient, or the generated insulin cannot be used in the body, resulting a long-term metabolic disorder. Diabetes affects an estimated 537 million adults worldwide between the age of 20 to 79 (10.5% of all adults in this age range). By 2030, 643 million people will have diabetes globally, increasing to 783 million by 2045. According to the IDF 10th edition, Read More
-
-
-
Bioactive Vitamins and Epigenetic Modifications in Diabetes: A Perspective
Diabetes is a complex metabolic disease that has been associated with epigenetic changes. External factors such as dietary patterns can induce an imbalance in the pools of micronutrients and macronutrients in the body. Consequently, bioactive vitamins may influence epigenetic mechanisms via several pathways: involvement in the control of gene expression, and in protein synthesis, by acting as coenzymes and co-factors in Read More
-
-
-
An Insight into the Pathogenesis of Diabetic Cardiomyopathy Along with the Novel Potential Therapeutic Approaches
Authors: Himangi Vig, Ravinandan AP, Hunsur N. Vishwas, Sachin Tyagi, Shruti Rathore, Ankita Wal and Pranay WalBackground: The existence of aberrant myocardial activity and function in the exclusion of those other cardiovascular events, such as atherosclerosis, hypertension, and severe valve disease, is known as diabetic cardiomyopathy. Diabetes patients are much more prone to death from cardiovascular illnesses than from any other cause, and they also have a 2–5 fold higher likelihood of acquiring cardiac failure and Read More
-
Volumes & issues
-
Volume 21 (2025)
-
Volume 20 (2024)
-
Volume 19 (2023)
-
Volume 18 (2022)
-
Volume 17 (2021)
-
Volume 16 (2020)
-
Volume 15 (2019)
-
Volume 14 (2018)
-
Volume 13 (2017)
-
Volume 12 (2016)
-
Volume 11 (2015)
-
Volume 10 (2014)
-
Volume 9 (2013)
-
Volume 8 (2012)
-
Volume 7 (2011)
-
Volume 6 (2010)
-
Volume 5 (2009)
-
Volume 4 (2008)
-
Volume 3 (2007)
-
Volume 2 (2006)
-
Volume 1 (2005)
Most Read This Month
Article
content/journals/cdr
Journal
10
5
false
en
